Clinical Trial Update: Evaluate the Safety and Efficacy of EN001 in Patients With Charcot-Marie-Tooth Disease Type 1A [Phase 1]

View source ↗

Summary

Phase 1 study evaluating EN001 for Charcot-Marie-Tooth disease type 1A has completed. The trial assessed safety and potential efficacy in patients with CMT1A.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Charcot-marie-tooth Disease Type 1a

Drugs mentioned

• EN001

Snippet

Sponsor: ENCell | Conditions: Charcot-Marie-Tooth Disease Type 1A | Phase 1 | Status: COMPLETED